4 growth stocks to put on your 2017 shopping list

Royston Wild runs the rule over some of London’s hottest growth stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The earnings story at BAE Systems (LSE: BA) has long been a turbulent one as crimped defence spending, along with uneven contract timings, has hindered the possibility of sustained growth.

But I believe a predicted 9% earnings bounce in 2017 should herald the return of steady earnings growth as a changing geopolitical landscape and rising terrorism boost arms budgets. On top of this, the imminent arrival of President Trump should also boost sales at the likes of BAE Systems should his pre-election bluster translate into new orders of major hardware.

As such, I reckon the firm’s P/E ratio of 14.1 times represents a decent level for growth hunters to pile-in at.

A sizzling growth stock

I’m convinced Domino’s Pizza Group (LSE: DOM) is also one to watch for those seeking breakneck earnings expansion.

The dough dynamo announced that underlying sales leapt 8.6% between January and September, reflecting the massive investment Domino’s has made in its online operations. Indeed, the company saw online orders shoot 18.1% higher during the third quarter from the same 2015 period.

And these numbers prompted Domino’s to turbocharge its store expansion programme last month, the firm now seeking to operate 1,600 outlets in the UK versus 1,200 previously.

The City expects Domino’s to enjoy a 13% earnings advance in 2017 alone. And while this results in a heady P/E rating of 22.9 times, I reckon the fast food giant’s ambitious growth plans justify such a multiple.

Global giant

I also believe the Homeserve (LSE: HSV) earnings outlook warrants serious attention as its strong sales momentum continues in North America.

The emergency call-out play saw total revenues explode 20% during April-September, with the number of US customers on its books 32% higher from the corresponding 2015 period. Wise acquisition activity and excellent retention rates are helping the top line to swell.

But Homeserve’s improving position across the Pond isn’t the only cause for celebration, the business also reporting chunky sales growth across the UK, France and Spain in the period.

These factors are expected to send earnings 16% higher in the year to March 2017 alone. And I reckon the prospect of further mouth-watering growth warrants a P/E ratio of 20.1 times.

In rude health

Pharma ace Dechra Pharmaceuticals (LSE: DPH) is also one to watch in the years ahead as its ongoing acquisition drive bolsters its global footprint, not to mention the company’s promising drugs pipeline.

News that the firm’s recently-purchased Putney division in the US received FDA approval to launch a generic antibiotic for cats and dogs underlined the company’s stunning sales potential. This is just one of a number of white-hot products Dechra is developing that could see the company double the size of its business in the States.

With demand for its products moving steadily higher, the number crunchers expect Dechra to print a 26% earnings advance in the 12 months to June 2017. And while a P/E multiple of 23.4 times may be heady on paper, a sub-1 PEG reading suggests the pharma giant is actually great value relative to its growth prospects.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Domino's Pizza and Homeserve. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »